Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder and the most prevalent cause of dementia with ageing. The etiology of this illness is rather complex and not completely known but deposits of aberrant β- amyloid protein, as well as τ-protein hyperphosphorylation, oxidative stress, dyshomeostasis of biometals and low levels of… (More)

Topics

Cite this paper

@article{Yez2013DualIO, title={Dual inhibitors of monoamine oxidase and cholinesterase for the treatment of Alzheimer disease.}, author={Matilde Y{\'a}{\~n}ez and Dolores Vi{\~n}a}, journal={Current topics in medicinal chemistry}, year={2013}, volume={13 14}, pages={1692-706} }